Europe
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Celyad is focusing on advancing chimeric antigen receptor T cell (CAR T) therapies.
The Phase II trial, VLA150202, evaluated the safety and immunogenicity of VLA15 on 246 healthy adults aged 18 to 65 years old across the United States.
Sputnik Vaccine’s 91.6% efficacy against the original COVID-19 strain has stood up to peer review in The Lancet. But what’s the controversy, lets’s check it out.
Pfizer and BioNTech share data with FDA on COVID-19 vaccines for younger children as Sanofi pivot on its mRNA COVID-19 vaccine, shifting focus toward other infectious diseases instead.
Here’s a look at a few of the industry expansions that have been announced so far this month.
Eriksson said that HMNC Brain Health is a pioneer in developing precision medicine for the psychiatric space.
Diabetes player Novo Nordisk cut a deal this week, announcing a settlement agreement to put an end to a lawsuit filed in January 2017 by American Depository Receipt investors.
The analysis showed a 52-week glucose remission rate of 65.2% among the 69 patients being followed.
There was still some carryover from the European Society of Medical Oncology Congress 2021, but there was plenty of other clinical trial news last week. Here’s a look.
PRESS RELEASES